Androgen Receptor Signaling in Prostate Cancer and Therapeutic Strategies

SIMPLE SUMMARY: Early-stage and castration-sensitive prostate cancer (PCa) growth is solely mediated by androgen signaling pathways. AR signaling inhibitors (ARSIs) have significantly improved clinical outcomes among men with PCa. In the metastatic castration-resistant PCa, there is presence of both...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacob, Aasems, Raj, Rishi, Allison, Derek B., Myint, Zin W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582395/
https://www.ncbi.nlm.nih.gov/pubmed/34771580
http://dx.doi.org/10.3390/cancers13215417

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582395/
https://www.ncbi.nlm.nih.gov/pubmed/34771580
http://dx.doi.org/10.3390/cancers13215417

Ejemplares similares